APPROACH: Non-viral mediated platform for genetic medicines designed to be durable and redosable
STRATEGIC AREA: Non-viral mediated DNA delivery genetic medicines for inheritable diseases including bleeding disorders
P2C FUNDING IMPACT: Treatment of bleeding disorders including Hemophilia A & B with potential for additional rare bleeding disorders